• Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
  • Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
Mobile close button Mobile toggle button

Evgen Pharma Licensing and Clinical Programme Update

mel | 12 October 2022
Categories:

Post navigation

← AGM Presentation – Harnessing the Power of Sulforaphane
2022 Interim Results Presentation →
Copyright© 2023
  • Privacy Policy
  • Sitemap
Twitter Twitter linkedin linkedin
Get in touch